BEAM

Beam Therapeutics

Biotech · 8 tracked clinical trials

Clinical Pipeline

TrialPhaseStatusIndication
NCT06389877 PHASE1, PHASE2 RECRUITING Alpha 1-Antitrypsin Deficiency
NCT05456880 PHASE1, PHASE2 ACTIVE_NOT_RECRUITING Sickle Cell Disease
NCT06735755 PHASE1, PHASE2 RECRUITING Glycogen Storage Disease Type Ia
NCT05885464 PHASE1, PHASE2 ACTIVE_NOT_RECRUITING Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
NCT06934382 PHASE1 RECRUITING T-Cell Acute Lymphoblastic Leukemia/Lymphoma
NCT07304791 PHASE1 RECRUITING Healthy Subjects, Healthy Participant Study
NCT07373639 RECRUITING Hemoglobinopathy, Sickle Cell Disease
NCT06071377 RECRUITING Sickle Cell Trait

Partnerships & Collaborations

PartnerTypeAnnouncedDetails
No partnerships tracked yet.

Recent news

DateHeadlineSource
2026-08-26 Beam Therapeutics (BEAM) Stock May Look Stretched As Sales Expectations Climb - Yahoo Finance Google News
2026-08-25 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com Google News
2026-08-25 BEAM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $80 - GuruFocus Google News
2026-08-25 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com Google News
2026-08-25 Beam Therapeutics Market Sentiment - Benzinga España Google News
2026-08-21 BEAM Stock Price, Quote & Chart - ChartMill Google News
2026-08-20 Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 6.2% - Here's What Happened - MarketBeat Google News
2026-08-19 Beam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Should You Buy? - MarketBeat Google News
2026-08-18 Alphabet Inc. Purchases New Shares in Beam Therapeutics Inc. $BEAM - MarketBeat Google News
2026-08-17 Beam Therapeutics Inc. (NASDAQ:BEAM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat Google News
2026-08-16 Beam Therapeutics (NASDAQ:BEAM) Downgraded by Wall Street Zen to "Strong Sell" - MarketBeat Google News
2026-08-14 Beam Therapeutics (BEAM): ARK Investment and Cathie Wood report 9.95% stake - Stock Titan Google News
2026-08-13 Farallon funds report 10.28M-share, 9.99% Beam Therapeutics (BEAM) position - Stock Titan Google News
2026-08-11 Equities Analysts Offer Predictions for BEAM Q3 Earnings - MarketBeat Google News
2026-08-10 Analyst Forecasts Just Became More Bearish On Beam Therapeutics Inc. (NASDAQ:BEAM) - simplywall.st Google News
2026-08-10 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com Google News
2026-08-10 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com Google News
2026-08-10 Weekly Recap: H1 2026 financials and BEAM-302 pivotal cohort dosing - TradingView Google News
2026-08-10 Analyst Forecasts Just Became More Bearish On Beam Therapeutics Inc. (NASDAQ:BEAM) - Sahm Google News
2026-08-10 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy By Investing.com - Investing.com Nigeria Google News